Bio-based Elastomer for Biopharmacuetical Tubing
Avient introduced its Versaflex elastomer formulated with bio-derived content.
Avient Corporation announced the availability of Versaflex HC BIO, thermoplastic elastomer (TPE) with bio-based content. Developed as an alternative for biopharmaceutical tubing, the initial Versaflex HC BIO BT218 grade is formulated with nearly 40% first-generation biomass content, resulting in a lower carbon footprint than traditional options.
Avient new product is aimed at tubing for pharmacuetical applications.
Photo Credit: Avient Corporation
The 71 Shore A formulation provides critical application performance such as weldability, kink resistance, and tensile strength comparable to leading medical tubing materials, including silicone and standard TPEs. The bio-derived grade offers greenhouse gas emissions at 2.35 kg CO2e / kg product, a nearly 25 percent lower cradle-to-gate product carbon footprint than Avient’s standard Versaflex HC BT218 grade. Avient’s product carbon footprint calculation method follows the ISO 14067:2018 standard and is certified by TUV Rheinland, an independent testing service company.
Certified for USP Class VI and ISO 10993, the new Versaflex HC BIO BT218 grade is manufactured in the United States with global commercial availability.
Related Content
-
Advanced Plastomers for Production of PE-Based Sealant Resins
Nova Chemicals’ new Astute products are suitable for a broad range of applications including food packaging, heavy-duty sacks and e-commerce.
-
Foster Adds Specialty TPU and TPU Alloy Products to its Arsenal of Healthcare Materials
AdvanSource Biomaterials’ specialty TPU materials are used in application segments such as cardiology, orthopedics, drug delivery, endoscopy, wound care, urology, and neurology.
-
Tracing the History of Polymeric Materials -- Part 30: Polyurethane
In the world of polymers, polyurethane chemistry is probably the most versatile. This a resulted in a wide range of products made from these materials and given the industry the flexibility to respond to the progressive march of regulatory concerns.
